The estimated Net Worth of Angel Cabrera is at least $495 Tausend dollars as of 8 May 2020. Angel Cabrera owns over 8,013 units of Inovio Pharmaceuticals Inc stock worth over $495,193 and over the last 12 years Angel sold INO stock worth over $0.
Angel has made over 4 trades of the Inovio Pharmaceuticals Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Angel exercised 8,013 units of INO stock worth $52,485 on 8 May 2020.
The largest trade Angel's ever made was buying 75,000 units of Inovio Pharmaceuticals Inc stock on 15 August 2012 worth over $44,250. On average, Angel trades about 8,734 units every 188 days since 2012. As of 8 May 2020 Angel still owns at least 75,602 units of Inovio Pharmaceuticals Inc stock.
You can see the complete history of Angel Cabrera stock trades at the bottom of the page.
Angel's mailing address filed with the SEC is 660 W Germantown Pike #100, Plymouth Meeting, PA 19462, USA.
Over the last 19 years, insiders at Inovio Pharmaceuticals Inc have traded over $23,656,819 worth of Inovio Pharmaceuticals Inc stock and bought 1,958,377 units worth $5,174,071 . The most active insiders traders include Austin W & Greenhouse David..., Jong Joseph Kim und Felix Theeuwes. On average, Inovio Pharmaceuticals Inc executives and independent directors trade stock every 22 days with the average trade being worth of $745,390. The most recent stock trade was executed by Michael John Sumner on 30 June 2024, trading 2,917 units of INO stock currently worth $19,106.
inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.
Inovio Pharmaceuticals Inc executives and other stock owners filed with the SEC include: